CAI is one of the largest life science consultancy companies in North America, Europe, and the Far East. The company excels in commissioning and validation related services and offers a wide range of consultancy services tailored for the life science industries. Since its founding in 1996, CAI has delivered over 1.25 billion dollars in services for hundreds of clients across thousands of projects, each valued up to $30 million. With more than 850 global employees, CAI reported topline sales exceeding $156 million last year, with operations across various countries including Australia, Canada, China, India, Ireland, Switzerland, Italy, Malaysia, The Netherlands, Singapore, Korea, the United Kingdom, and the United States. CAI is a recognised leader in the fields of pharmaceuticals, advanced therapy medicinal products (ATMP), and biotechnology/Fill Finish commissioning, qualification, and validation (CQV), noted for its expertise in industry standards and requirements, project management, and project dynamics.

Services include:
– Biopharmaceuticals
– Contract Development and Manufacturing (CDMO)
– Commissioning, Qualification, and Validation (CQV)
– Regulatory Compliance Consulting
– Quality Assurance and Quality Control
– Project Management

CAI’s extensive expertise and broad range of services position it as a pivotal player in the life sciences industry. For more information, please visit cagents.com.